Committed to improving the quality of lives by researching and manufacturing cannabinoids for use in approved medicines with an initial focus on chronic pain – utilising the best global technology, manufacturing practices and data science to drive innovation and efficiencies.
Celadon is a UK based pharmaceutical company specialising in the manufacture and development of medicinal cannabis-derived drugs for the treatment of chronic pain and other ailments such as autism and multiple sclerosis.
Celadon works with leading scientists, agronomists and specialists at its world-class facility. Technology, research and development are key drivers behind our revolutionary medicinal developments.
Patient quality of life is at the heart of everything we do here at Celadon. Cannabinoid medicines have been developed to ensure that together, with the right support, lives can be significantly improved.
Input your search keywords and press Enter.